Capricor

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.

About CAPR

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps.

CEO

Linda Marbán

CEOLinda Marbán

Employees

102

Employees102

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1996

Founded1996

Employees

102

Employees102

CAPR Key Statistics

Market cap

768.78M

Market cap768.78M

Price-Earnings ratio

-18.18

Price-Earnings ratio-18.18

Dividend yield

—

Dividend yield—

Average volume

1.04M

Average volume1.04M

High today

$18.58

High today$18.58

Low today

$15.75

Low today$15.75

Open price

$18.19

Open price$18.19

Volume

1.72M

Volume1.72M

52 Week high

$23.40

52 Week high$23.40

52 Week low

$2.80

52 Week low$2.80

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

Capricor

Why Robinhood?

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. Show more

CAPR Key Statistics

Analyst ratings

100%

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps.